Evidence map›Paper›PMID 20011981›Full record

ReviewActa biochimica et biophysica Sinica2009

Proteolytic regulatory mechanism of chemerin bioactivity.

Xiao-Yan Du, Lawrence L K Leung

Abstract readReview
In one paragraph

Review in Acta biochimica et biophysica Sinica, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Chemerin as a Driver of Hypertension: A Consideration.American journal of hypertension · 2020
    Review
  13. Adipokines and Inflammation: Focus on Cardiovascular Diseases.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Xiao-Yan DuDivision of Hematology, Stanford University School of Medicine, Stanford, CA 94305, USA. duxiaoyan@hotmail.com
Lawrence L K Leung
Stanford University · USVA Palo Alto Health Care System · US

Funding

FUNCTIONAL MAPPING AND PROTEIN ENGINEERING OF THROMBINR01HL057530 · NHLBI · STANFORD UNIVERSITY · PI LEUNG, LAWRENCE L · 1999 to 2013
$4.2M
NHLBI NIH HHS R01 HL57530
6 · The paper itself

Abstract

Chemerin is a novel chemoattractant recognized by chemokine-like receptor 1 (CMKLR1), a serpentine receptor expressed primarily by plasmacytoid dendritic cells, natural killer cells, and macrophages. Human prochemerin circulates in plasma as an inactive precursor. Its chemotactic activity is expressed upon cleavage of the C-terminal amino acid residues by proteases of the coagulation, fibrinolytic, and inflammatory system. The C-terminal cleavage site of prochemerin is highly conservative, indicating that the proteolytic regulation of chemerin bioactivity is a common mechanism undertaken by different species. In this review, we summarized chemerin-proteases interactions, chemerin receptors, and their importance in normal and pathologic conditions.

Indexed as

Amino Acid SequenceAnimalsBiological FactorsChemokinesEnzyme ActivatorsHumansInflammationMolecular Sequence DataPeptide HydrolasesReceptors, ChemokineBiological FactorsChemokinesEnzyme ActivatorsPeptide HydrolasesReceptors, Chemokine

Identifiers

PMID20011981
PMCPMC2788413
OpenAlexW2151163521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.